MIR6088

Across TCGA pan-cancer cohorts, MIR6088 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of MIR6088’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where MIR6088 RNA is repressed in tumor relative to normal tissue. In most cancer types MIR6088 is over-expressed in tumor, although a few such as THCA and LUSC show the opposite, repressed pattern.

THCA, LUSC, and ESCA are the cancer types where MIR6088 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR6088 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	Female	All	−0.414	<.001	4	view →
LUSC	All	II,III,IV	−0.500	.015	2	view →
ESCA	Female	All	+1.086	.046	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

MIR6088–THCA

Open the THCA breakdown →